Net Income (Loss) per Share (Tables)

3 Months Ended

Mar. 31, 2023

Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders

Basic and diluted net income (loss) per share attributable to common stockholders was calculated as follows:


	Three months ended March 31,
	2023		2022

Basic net income (loss) per share:
Numerator:
Net income (loss)	$	(19,741)	$	6,199
Denominator:
Weighted average commons shares outstanding — basic	60,627,993		48,606,055
Net income (loss) per share — basic	$	(0.33)	$	0.13

Diluted net income (loss) per share:
Numerator:
Net income (loss) - basic	$	(19,741)	$	6,199
Interest expense on convertible note payable	—		122
Net income (loss) - diluted	$	(19,741)	$	6,321
Denominator:
Weighted average commons shares outstanding — basic	60,627,993		48,606,055
Shares issuable upon conversion of convertible notes, as if converted	—		832,677
Dilutive effect of restricted stock units	—		230
Dilutive effect of common stock equivalents	—		377,822
Weighted average common shares outstanding - diluted	60,627,993		49,816,784
Net income (loss) per share — diluted	$	(0.33)	$	0.13

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated above because including them would have had an anti-dilutive effect:


			March 31,
			2023
Stock options to purchase common stock			11,401,531
Shares to be issued under the 2018 ESPP			1,873,627
RSU’s issued and expected to vest			385,980
Shares available from conversion of note payable			2,506,306
			16,167,444